Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Update on the Odyssey
When every fifth taxi in downtown San Francisco is carrying an ad for Byetta, FlexPen, or FreeStyle meters, you know the American Diabetes Association (ADA) is in town.
The woman who's been on insulin longer than anyone
During this year’s Super Bowl, a commercial for the American Heart Association’s online risk calculator caught Americans in the act – of stuffing their faces with corn...
Patients who would prefer a larger display and larger buttons on their blood glucose meter may want to give the FreeStyle Freedom Lite a try. This meter from Abbott was...
Diabetes devices with cell phone technology, data analytics, and a touchscreen? diaTribe’s own Adam Brown test drives the newest blood glucose meters...
GLP-1 agonists (for example, Byetta , Victoza , and Bydureon ) were first approved in 2005 and stimulate the body to produce insulin only when blood glucose levels...
(S)he said what?!?
European Diabetes Technology and Transplantation Meeting, and ADA Postgraduate Sessions
Once only a measure used by health agencies, Body Mass Index, or BMI, is now the trendy gauge of girth as people pass over pounds as passé. You know the scales have...
Inhaled Insulin: Into Thin Air?
(S)he said what?!?
Looking through this special issue on the American Diabetes Association meeting this year, I can’t help but feel two things – pride and trepidation.
All diabetes is personal.
In April, the FDA approved the FreeStyle Lite meter, which requires no coding. It’s similar to the very small FreeStyle Flash, though apparently won’t be replacing it at...
You can send supplies to Insulin for Life at: OUHSC Department of Endocrinology & Diabetes Attn: Becky Mosley 920 Stanton L. Young Blvd., WP 1345 Oklahoma City, OK...
How might diabetes devices improve in the future? Kerri Morrone Sparling offers us her wish list.
Earlier this month, an initial regulatory assessment committee recommended the novel type 2 diabetes therapy dapagliflozin (Forxiga) for approval in Europe. A final...
A challenge to the Acting Surgeon General.
The Wonders of Byetta: One Man’s Weight-Loss Journey

Pages